SAB Research Grant Application

The Scientific Advisory Board of Vivere, is pleased to announce the availability of 3 grants of $10,000 each for reproductive endocrinology and infertility fellows whose research goals reflect the mission and goals of the board.
As an organization of clinical advisors dedicated to shaping the future of women’s health and reproductive medicine, we know how important continuing education is to our medical professionals. Our five-member board of fertility and reproductive health experts is able to provide these types of educational opportunities through support from our sponsor, Vivere a fertility management and equity partner.

The Scientific Advisory Board provides financial support, oversees medical research and sponsors scientific education to advance fertility care and meet the long-term reproductive health needs of physicians and patients nationwide.

The mission of the board is to bring young people to thought leaders by support of residents/fellows in scientific research and knowledge.

The goals of the board include:

  • support residents/fellow attendance at national meetings/programs;
  • support education programs;
  • support scientific research;
  • promote business aspects of SREI

Special consideration for the grants will be given to applicants that contain business or economic models to improve REI business practices.


Research Grant Application

 

  • Provide a brief description of the medical questions(s) and the rationale of how this study attempts to answer the question. Provide a rational schedule outline for all treatment arms and any relevant preliminary data.
  • List the study hypotheses in order of priority (clearly state any specific hypotheses to be tested). The primary efficacy and safety hypothesis correspond directly with the primary objective.
  • List the primary and secondary objective(s) to correspond directly with the listed hypotheses (including the main study goal) study primary endpoint will be linked to the justification of the sample size and brief definition of the secondary objective(s).
  • State the type of experimental design (i.e. randomized, crossover, controlled, open or blinded). Specify sample size and study population gender and other demographic information concerning the selected population. List key inclusion and exclusion criteria necessary to design and drug safety requirements.
  • Specify dose, schedule, duration, route of administration, any pre-medication, etc.
  • Specify type and frequency of safety, efficacy, and outcome measures (including biomarker, PK, etc.) and indicate methods(s) to analyze.
  • Describe the planned statistical analysis including timing of the primary and secondary measures and sample size calculation. At a minimum assumptions surrounding the reporting of the primary endpoint should be included.
  • Drop files here or
  • Drop files here or
  • Drop files here or
  • Drop files here or
  • List references, studies, and sources that support the study.

If you have any questions regarding the Scientific Advisory Board grant application, please send us an email.